Aclaris Therapeutics, Inc. (LON:0H8T)

Aclaris Therapeutics Statistics

Total Valuation

LON:0H8T has a market cap or net worth of GBP 143.52 million. The enterprise value is 12.85 million.

Market Cap	143.52M
Enterprise Value	12.85M

Important Dates

The next estimated earnings date is Thursday, November 6, 2025.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	108.33M
Shares Outstanding	n/a
Shares Change (YoY)	+44.96%
Shares Change (QoQ)	+0.16%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	72.65M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	11.71
PB Ratio	1.49
P/TBV Ratio	1.49
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.13
EV / Sales	1.05
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1.75

Financial Position

The company has a current ratio of 3.88, with a Debt / Equity ratio of 0.02.

Current Ratio	3.88
Quick Ratio	3.73
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	-0.24
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -101.41% and return on invested capital (ROIC) is -26.98%.

Return on Equity (ROE)	-101.41%
Return on Assets (ROA)	-20.86%
Return on Invested Capital (ROIC)	-26.98%
Return on Capital Employed (ROCE)	-36.00%
Revenue Per Employee	194,513
Profits Per Employee	-1.56M
Employee Count	64
Asset Turnover	0.10
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +64.55% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+64.55%
50-Day Moving Average	1.72
200-Day Moving Average	2.01
Relative Strength Index (RSI)	50.29
Average Volume (20 Days)	7,873

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.96

Income Statement

In the last 12 months, LON:0H8T had revenue of GBP 12.25 million and -98.28 million in losses. Loss per share was -0.96.

Revenue	12.25M
Gross Profit	-26.50M
Operating Income	-42.65M
Pretax Income	-98.28M
Net Income	-98.28M
EBITDA	-42.52M
EBIT	-42.65M
Loss Per Share	-0.96

Balance Sheet

The company has 72.85 million in cash and 1.73 million in debt, giving a net cash position of 130.30 million.

Cash & Cash Equivalents	72.85M
Total Debt	1.73M
Net Cash	130.30M
Net Cash Per Share	n/a
Equity (Book Value)	96.16M
Book Value Per Share	0.89
Working Capital	56.47M

Cash Flow

In the last 12 months, operating cash flow was -7.29 million and capital expenditures -46,714, giving a free cash flow of -7.34 million.

Operating Cash Flow	-7.29M
Capital Expenditures	-46,714
Free Cash Flow	-7.34M
FCF Per Share	n/a

Margins

Gross Margin	-216.22%
Operating Margin	-348.04%
Pretax Margin	-802.03%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LON:0H8T does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-44.96%
Shareholder Yield	n/a
Earnings Yield	-68.48%
FCF Yield	-5.11%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0H8T has an Altman Z-Score of -5.54 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.54
Piotroski F-Score	1